Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...
Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Ivonescimab, a drug that combines the activity of two of the best-selling cancer medicines, reduced the risk of ...
Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks ...
An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to results being presented at the American Society of ...
Lilly's upcoming label expansion proposal for 2020-approved Retevmo is "in many ways, the final chapter of the development program" for the drug, oncology head Jacob Van Naarden said in an interview. ...
Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The Iron Lung movie based on the video game from YouTube creator ...
Revolution Medicines focuses on developing drugs for RAS-addicted cancers. RAS is a family of proteins that act as molecular switches in controlling cell growth. They can be turned "on" or "off." In ...
Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But efforts to find preventive drugs and vaccines are starting to bear fruit. New ...
Norway’s Crown Princess Mette-Marit has been placed on a waiting list for a transplant due to “life-threatening chronic lung disease,” the country’s royal household has announced. The 52-year-old ...
U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...
A new drug that targets a gene behind pancreatic cancer has physicians and researchers cautiously optimistic about improved treatment for one of the deadliest cancers. Researchers found that a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results